After adjusting for key confounders, including body mass index (BMI), lifestyle factors, inflammatory markers, and polygenic risk scores (PRS), CHIP was associated with a 19% increased risk of breast cancer (adjusted OR = 1.19, P = 1.77e-04). The gene discussed is STUB1; the disease is breast carcinoma.